Vitamin D in "early" primary Sjögren's syndrome: Does it play a role in influencing disease phenotypes?

Rheumatology International

Volumn 34, Issue 8, 2014, Pages 1159-1164

  Baldini, Chiara ^a   Delle Sedie, Andrea ^a   Luciano, Nicoletta ^a   Pepe, Pasquale ^a   Ferro, Francesco ^a   Talarico, Rosaria ^a   Tani, Chiara ^a   Mosca, Marta ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Pathogenesis; Sj gren's syndrome; Vitamin D deficiency

Indexed keywords

25 HYDROXYVITAMIN D; VITAMIN D; BIOLOGICAL MARKER; CALCIFEDIOL;

ADULT; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; DISEASE SEVERITY; FEMALE; HUMAN; IMMUNORADIOMETRIC ASSAY; LEUKOCYTE COUNT; LEUKOPENIA; MAJOR CLINICAL STUDY; PATHOGENESIS; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; SJOEGREN SYNDROME; VITAMIN DEFICIENCY; AGED; BLOOD; MALE; MIDDLE AGED; PREDICTIVE VALUE; PROSPECTIVE STUDY; SEVERITY OF ILLNESS INDEX; SJOGREN'S SYNDROME; VITAMIN D DEFICIENCY;

ADULT; AGED; BIOLOGICAL MARKERS; CALCIFEDIOL; FEMALE; HUMANS; IMMUNORADIOMETRIC ASSAY; MALE; MIDDLE AGED; PHENOTYPE; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SJOGREN'S SYNDROME; VITAMIN D DEFICIENCY;

EID: 84904808387     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-013-2872-3     Document Type: Article

References (28)

1. Cutolo M, Plebani M, Shoenfeld Y, Adorini L, Tincani A (2011) Vitamin D endocrine system and the immune response in rheumatic diseases. Vitam Horm 86:327-351
2. Vacca A, Cormier C, Mathieu A, Kahan A, Allanore Y (2011) Vitamin D levels and potential impact in systemic sclerosis. Clin Exp Rheumatol 29(6):1024-1031
3. Di Munno O, Mazzantini M, Delle Sedie A, Mosca M, Bombardieri S (2004) Risk factors for osteoporosis in female patients with systemic lupus erythematosus. Lupus 13(9):724-730 (Pubitemid 39279792)
4. Hélou J, Moutran R, Maatouk I, Haddad F (2013) Raynaud's phenomenon and vitamin D. Rheumatol Int 33(3):751-755
5. Muller K, Oxholm P, Sorensen OH, Thymann M, Hoier-Madsen M, Bendtzen K (1990) Abnormal vitamin D3 metabolism in patients with primary Sjogren's syndrome. Ann Rheum Dis 49(9):682-684 (Pubitemid 20279118)
6. Szodoray P, Horvath IF, Papp G, Barath S, Gyimesi E, Csathy L, Kappelmayer J, Sipka S, Duttaroy AK, Nakken B et al (2010) The immunoregulatory role of vitamins A, D and E in patients with primary Sjogren's syndrome. Rheumatology (Oxford) 49(2):211-217
7. Baldini C, Pepe P, Luciano N, Ferro F, Talarico R, Grossi S, Tavoni A, Bombardieri S (2012) A clinical prediction rule for lymphoma development in primary Sjogren's syndrome. J Rheumatol 39(4):804-808
8. Voulgarelis M, Tzioufas AG, Moutsopoulos HM (2008) Mortality in Sjogren's syndrome. Clin Exp Rheumatol 26(5 Suppl 51):S66-S71
9. Tzioufas AG, Voulgarelis M (2007) Update on Sjogren's syndrome autoimmune epithelitis: from classification to increased neoplasias. Best Pract Res Clin Rheumatol 21(6):989-1010 (Pubitemid 350194037)
10. Baldini C, Giusti L, Bazzichi L, Lucacchini A, Bombardieri S (2008) Proteomic analysis of the saliva: a clue for understanding primary from secondary Sjogren's syndrome? Autoimmun Rev 7(3):185-191
11. Baldini C, Giusti L, Ciregia F, Da Valle Y, Giacomelli C, Donadio E, Sernissi F, Bazzichi L, Giannaccini G, Bombardieri S et al (2011) Proteomic analysis of saliva: a unique tool to distinguish primary Sjogren's syndrome from secondary Sjogren's syndrome and other sicca syndromes. Arthr Res Ther 13(6):R194
12. Baldini C, Talarico R, Tzioufas AG, Bombardieri S (2012) Classification criteria for Sjogren's syndrome: a critical review. J Autoimmun 39(1-2):9-14
13. Ramos-Casals M, Brito-Zeron P, Perez-De-Lis M, Jimenez I, Blanco MJ, Bove A, Soto MJ, Akasbi M, Diaz C, Sentis J et al (2010) Sjogren syndrome or sjogren disease? The histological and immunological bias caused by the 2002 criteria. Clin Rev Allergy Immunol 38(2-3):178-185
14. Giusti L, Baldini C, Bazzichi L, Bombardieri S, Lucacchini A (2007) Proteomic diagnosis of Sjogren's syndrome. Exp Rev Proteomics 4(6):757-767
15. Albrecht J, Atzeni F, Baldini C, Bombardieri S, Dalakas MC, Demirkesen C, Yazici H, Mat C, Werth VP, Sarzi-Puttini P (2006) Skin involvement and outcome measures in systemic autoimmune diseases. Clin Exp Rheumatol 24(1 Suppl 40):S52-S59
16. Agmon-Levin N, Kivity S, Tzioufas AG, Lopez Hoyos M, Rozman B, Efes I, Shapira Y, Shamis A, Amital H, Youinou P (2012) Low levels of vitamin-D are associated with neuropathy and lymphoma among patients with Sjogren's syndrome. J Autoimmun 39(3):234-239
17. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM (2012) Guidelines for preventing and treating vitamin D deficiency and insufficiency revisited. J Clin Endocrinol Metab 97(4):1153-1158
18. Bang B, Asmussen K, Sorensen OH, Oxholm P (1999) Reduced 25-hydroxyvitamin D levels in primary Sjogren's syndrome. Correlations to disease manifestations. Scand J Rheumatol 28(3):180-183 (Pubitemid 29298014)
19. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox RI, Kassan SS et al (2002) Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61(6):554-558 (Pubitemid 34539104)
20. Seror R, Ravaud P, Bowman SJ, Baron G, Tzioufas A, Theander E, Gottenberg JE, Bootsma H, Mariette X, Vitali C (2010) EULAR Sjogren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren's syndrome. Ann Rheum Dis 69(6):1103-1109
21. Adami S, Romagnoli E, Carnevale V, Scillitani A, Giusti A, Rossini M, Gatti D, Nuti R, Minisola S (2011) Guidelines on prevention and treatment of vitamin D deficiency. Reumatismo 63(3):129-147
22. Rosen CJ, Gallagher JC (2011) The 2011 IOM report on vitamin D and calcium requirements for north america: clinical implications for providers treating patients with low bone mineral density. J Clin Densitom 14(2):79-84
23. Romagnoli E, Caravella P, Scarnecchia L, Martinez P, Minisola S (1999) Hypovitaminosis D in an Italian population of healthy subjects and hospitalized patients. Br J Nut 81(2):133-137 (Pubitemid 29103621)
24. Isaia G, Giorgino R, Rini GB, Bevilacqua M, Maugeri D, Adami S (2003) Prevalence of hypovitaminosis D in elderly women in Italy: clinical consequences and risk factors. Osteoporos Int 14(7):577-582 (Pubitemid 36975557)
25. Rossini M, D'Avola G, Muratore M, Malavolta N, Silveri F, Bianchi G, Frediani B, Minisola G, Sorgi ML, Varenna M et al (2013) Regional differences of vitamin D deficiency in rheumatoid arthritis patients in Italy. Reumatismo 65(3):113-120
26. Antico A, Tampoia M, Tozzoli R, Bizzaro N (2012) Can supplementation with vitamin D reduce the risk or modify the course of autoimmune diseases? A systematic review of the literature. Autoimmun Rev 12(2):127-136
27. Kriegel MA, Manson JE (2011) Costenbader KH Does vitamin D affect risk of developing autoimmune disease?: a systematic review. Semin Arthritis Rheum 40(6):512-531
28. Bogaczewicz J, Sysa-Jedrzejowska A, Arkuszewska C, Zabek J, Kontny E, McCauliffe D, Wozniacka A (2012) Vitamin D status in systemic lupus erythematosus patients and its association with selected clinical and laboratory parameters. Lupus 21(5):477-484